NASDAQ:FPRX - Five Prime Therapeutics SEC Filings & 10K Form

Sign in or create an account to add this stock to your watchlist.
$11.72 +0.14 (+1.21 %)
(As of 02/19/2019 03:37 PM ET)
Previous Close$11.58
Today's Range$11.54 - $11.99
52-Week Range$7.84 - $22.75
Volume90,744 shs
Average Volume292,138 shs
Market Capitalization$415.66 million
P/E Ratio-2.18
Dividend YieldN/A
Beta3.08

SEC Filings

Five Prime Therapeutics (NASDAQ:FPRX) SEC Filings

DateFilerForm TypeView
02/14/2019
3:04 PM
Five Prime Therapeutics (Subject)
GREAT POINT PARTNERS LLC (Filed by)
Form SC 13G/A
View Filing
02/13/2019
10:52 AM
Five Prime Therapeutics (Subject)
FMR LLC (Filed by)
Form SC 13G/A
View Filing
02/13/2019
5:50 AM
Five Prime Therapeutics (Subject)
STATE STREET CORP (Filed by)
Form SC 13G/A
View Filing
02/12/2019
8:43 AM
Five Prime Therapeutics (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SC 13G/A
View Filing
02/11/2019
8:29 AM
Five Prime Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
View Filing
02/07/2019
4:24 PM
Five Prime Therapeutics (Issuer)
Sarena Francis Willard (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
02/07/2019
4:21 PM
Collins Helen Louise (Reporting)
Five Prime Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
02/07/2019
4:18 PM
Five Prime Therapeutics (Issuer)
Williams Lewis T (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
02/07/2019
4:14 PM
Five Prime Therapeutics (Issuer)
Knickerbocker Aron Marc (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
01/15/2019
3:08 PM
Five Prime Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
01/11/2019
5:07 PM
Five Prime Therapeutics (Issuer)
RINGO WILLIAM R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
01/07/2019
5:10 AM
Five Prime Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
11/29/2018
3:10 PM
Five Prime Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
11/27/2018
6:21 PM
Five Prime Therapeutics (Issuer)
Smith David V (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
11/27/2018
6:10 PM
Five Prime Therapeutics (Issuer)
Smith David V (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
View Filing
11/13/2018
7:32 PM
Five Prime Therapeutics (Issuer)
Williams Lewis T (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
11/05/2018
8:05 AM
Five Prime Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
10/19/2018
3:00 PM
Five Prime Therapeutics (Subject)
GREAT POINT PARTNERS LLC (Filed by)
Form SC 13G
View Filing
10/04/2018
4:09 PM
BIOTECHNOLOGY VALUE FUND L P (Filed by)
Five Prime Therapeutics (Subject)
Form SC 13G/A
View Filing
10/02/2018
5:50 PM
Five Prime Therapeutics (Issuer)
Knickerbocker Aron Marc (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
10/02/2018
5:46 PM
Five Prime Therapeutics (Issuer)
Sarena Francis Willard (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
10/02/2018
5:43 PM
Collins Helen Louise (Reporting)
Five Prime Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
09/27/2018
11:12 AM
Five Prime Therapeutics (Issuer)
Knickerbocker Aron Marc (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
09/25/2018
11:58 AM
Five Prime Therapeutics (Issuer)
Knickerbocker Aron Marc (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
09/20/2018
11:29 AM
Five Prime Therapeutics (Issuer)
Knickerbocker Aron Marc (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
09/18/2018
11:57 AM
Five Prime Therapeutics (Issuer)
Knickerbocker Aron Marc (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
09/12/2018
2:46 PM
Five Prime Therapeutics (Issuer)
Knickerbocker Aron Marc (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
09/06/2018
12:45 PM
Five Prime Therapeutics (Issuer)
Knickerbocker Aron Marc (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
09/05/2018
12:05 PM
Five Prime Therapeutics (Issuer)
Knickerbocker Aron Marc (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
09/05/2018
12:03 PM
Five Prime Therapeutics (Issuer)
Knickerbocker Aron Marc (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
09/05/2018
12:00 PM
Five Prime Therapeutics (Issuer)
Williams Lewis T (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
09/05/2018
10:27 AM
Five Prime Therapeutics (Issuer)
Sarena Francis Willard (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
09/05/2018
10:24 AM
Five Prime Therapeutics (Issuer)
Irving Bryan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
09/05/2018
10:22 AM
Collins Helen Louise (Reporting)
Five Prime Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
09/04/2018
4:24 PM
BIOTECHNOLOGY VALUE FUND L P (Filed by)
Five Prime Therapeutics (Subject)
Form SC 13G
View Filing
08/28/2018
9:06 AM
Five Prime Therapeutics (Issuer)
Knickerbocker Aron Marc (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
08/23/2018
2:33 PM
Five Prime Therapeutics (Issuer)
Knickerbocker Aron Marc (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
08/22/2018
1:38 PM
Five Prime Therapeutics (Issuer)
Knickerbocker Aron Marc (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
08/21/2018
11:54 AM
Five Prime Therapeutics (Issuer)
Knickerbocker Aron Marc (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
08/16/2018
12:18 PM
Five Prime Therapeutics (Issuer)
Knickerbocker Aron Marc (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
08/14/2018
2:18 PM
Five Prime Therapeutics (Issuer)
Knickerbocker Aron Marc (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
08/08/2018
6:49 PM
Five Prime Therapeutics (Issuer)
Knickerbocker Aron Marc (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
08/08/2018
3:16 PM
Five Prime Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
View Filing
08/08/2018
3:11 PM
Five Prime Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
06/26/2018
7:16 PM
Collins Helen Louise (Reporting)
Five Prime Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/12/2018
12:09 PM
Five Prime Therapeutics (Issuer)
Knickerbocker Aron Marc (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/04/2018
5:07 AM
Five Prime Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
05/14/2018
7:26 PM
Five Prime Therapeutics (Issuer)
Irving Bryan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
05/14/2018
7:23 PM
Five Prime Therapeutics (Issuer)
RINGO WILLIAM R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
05/14/2018
7:21 PM
Five Prime Therapeutics (Issuer)
Nicholson Garry A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
05/14/2018
7:18 PM
Five Prime Therapeutics (Issuer)
MCDADE MARK (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
05/14/2018
7:15 PM
Five Prime Therapeutics (Issuer)
Jensen Peder (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
05/14/2018
6:47 PM
Dhingra Kapil (Reporting)
Five Prime Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
05/14/2018
5:51 PM
BERGER FRANKLIN M (Reporting)
Five Prime Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
05/14/2018
5:47 PM
Five Prime Therapeutics (Issuer)
Gujrathi Sheila (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
05/11/2018
3:06 PM
Five Prime Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
05/08/2018
3:23 PM
Five Prime Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
View Filing
05/08/2018
3:11 PM
Five Prime Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
04/23/2018
12:29 PM
Five Prime Therapeutics (Issuer)
Rubinstein Linda M (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
View Filing
04/17/2018
3:06 PM
Five Prime Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
04/10/2018
11:43 AM
Five Prime Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
04/09/2018
3:05 PM
Five Prime Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
03/30/2018
5:03 AM
Five Prime Therapeutics (Filer)
Form DEF 14A
View Filing
03/22/2018
1:50 PM
Collins Helen Louise (Reporting)
Five Prime Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
03/13/2018
3:11 PM
Five Prime Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
02/28/2018
6:32 PM
Five Prime Therapeutics (Issuer)
Knickerbocker Aron Marc (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
02/28/2018
6:29 PM
Five Prime Therapeutics (Issuer)
Irving Bryan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
02/28/2018
6:26 PM
Five Prime Therapeutics (Issuer)
Williams Lewis T (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
02/28/2018
6:24 PM
Belsky Marc (Reporting)
Five Prime Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
02/28/2018
6:23 PM
Baker Kevin Paul (Reporting)
Five Prime Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
02/28/2018
6:18 PM
Collins Helen Louise (Reporting)
Five Prime Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
02/28/2018
6:16 PM
Collins Helen Louise (Reporting)
Five Prime Therapeutics (Issuer)
Form 3/A
View Filing
02/28/2018
6:15 PM
Five Prime Therapeutics (Issuer)
Sarena Francis Willard (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
02/27/2018
3:10 PM
Five Prime Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
02/14/2018
6:24 AM
Five Prime Therapeutics (Subject)
STATE STREET CORP (Filed by)
Form SC 13G
View Filing
02/13/2018
10:46 AM
Five Prime Therapeutics (Issuer)
Williams Lewis T (Reporting)
Form 4/A
View Filing
02/13/2018
10:36 AM
Five Prime Therapeutics (Issuer)
Williams Lewis T (Reporting)
Form 4/A
View Filing
02/09/2018
5:40 AM
Five Prime Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
View Filing
02/08/2018
10:37 AM
Five Prime Therapeutics (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SC 13G/A
View Filing
02/07/2018
1:19 PM
Five Prime Therapeutics (Issuer)
Williams Lewis T (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
02/07/2018
1:15 PM
Belsky Marc (Reporting)
Five Prime Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
02/07/2018
1:05 PM
Collins Helen Louise (Reporting)
Five Prime Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
02/07/2018
1:03 PM
Baker Kevin Paul (Reporting)
Five Prime Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
02/02/2018
2:13 PM
Baker Kevin Paul (Reporting)
Five Prime Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
01/25/2018
3:11 PM
Five Prime Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
01/25/2018
3:07 PM
Five Prime Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
01/25/2018
3:04 PM
Five Prime Therapeutics (Filer)
Form 424B5
View Filing
01/23/2018
4:01 PM
Five Prime Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
01/23/2018
3:03 PM
Five Prime Therapeutics (Filer)
Form 424B5
View Filing
12/19/2017
3:11 PM
Five Prime Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
11/30/2017
6:19 PM
Five Prime Therapeutics (Issuer)
Knickerbocker Aron Marc (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
This page was last updated on 2/19/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel